Go Pro
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$62.81 +2.97 (+4.96%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$62.70 -0.11 (-0.17%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Advanced

Key Stats

Today's Range
$59.39
$63.57
50-Day Range
$53.43
$73.41
52-Week Range
$23.47
$77.00
Volume
63,035 shs
Average Volume
61,145 shs
Market Capitalization
$200.99 million
P/E Ratio
15.21
Dividend Yield
N/A
Price Target
$74.00
Consensus Rating
Moderate Buy

Company Overview

Pro-Dex, Inc. is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems. Pro-Dex combines in-house design, precision machining and assembly to support complex applications, ensuring tight tolerances and compliance with industry standards.

Headquartered in Irvine, California, Pro-Dex operates manufacturing and research facilities in the United States and maintains a global distribution network that spans North America, Europe and Asia. This geographic reach enables the company to provide technical support and aftermarket services to its customers worldwide.

Founded in 1975, Pro-Dex has built its reputation on engineering expertise, quality management and regulatory compliance. The company’s leadership team brings extensive experience in precision device manufacturing, product development and quality systems, guiding Pro-Dex through continuous expansion of its capabilities and market presence.

AI Generated. May Contain Errors.

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 65% of companies evaluated by MarketBeat, and ranked 303rd out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Pro-Dex has a consensus price target of $74.00, representing about 17.8% upside from its current price of $62.81.

  • Amount of Analyst Coverage

    Pro-Dex has only been the subject of 2 research reports in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 15.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 15.21, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.24.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 4.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    10.32% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 3.72, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently decreased by 7.92%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • News Sentiment

    Pro-Dex has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Pro-Dex this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for PDEX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,306,246.00 in company stock.

  • Percentage Held by Insiders

    45.90% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    15.28% of the stock of Pro-Dex is held by institutions.

  • Read more about Pro-Dex's insider trading history.
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PDEX Stock News Headlines

Pro-Dex (NASDAQ:PDEX) CFO Sells 2,300 Shares
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.tc pixel
Pro-Dex Inc.
See More Headlines

PDEX Stock Analysis - Frequently Asked Questions

Pro-Dex's stock was trading at $38.48 at the beginning of the year. Since then, PDEX shares have increased by 63.2% and is now trading at $62.81.

Pro-Dex, Inc. (NASDAQ:PDEX) released its earnings results on Thursday, September, 3rd. The medical instruments supplier reported $0.87 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.20. The medical instruments supplier had revenue of $20.40 million for the quarter, compared to the consensus estimate of $19.20 million. Pro-Dex had a net margin of 17.62% and a trailing twelve-month return on equity of 25.13%.

Top institutional shareholders of Pro-Dex include Bank of New York Mellon Corp (0.36%), Navellier & Associates Inc. (0.17%) and California State Teachers Retirement System (0.05%). Insiders that own company stock include Kirk Richard Lee Van Jr, Alisha Charlton and Angelita Rebamontan Domingo.
View institutional ownership trends
.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

Company Calendar

Last Earnings
9/03/2026
Today
9/12/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:PDEX
CIK
788920
Employees
140
Year Founded
1975

Price Target and Rating

High Price Target
$74.00
Low Price Target
$74.00
Potential Upside/Downside
+17.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.13
Trailing P/E Ratio
15.21
Forward P/E Ratio
22.59
P/E Growth
N/A
Net Income
$13.66 million
Net Margins
17.62%
Pretax Margin
23.23%
Return on Equity
25.13%
Return on Assets
16.02%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
4.10
Quick Ratio
2.45

Sales & Book Value

Annual Sales
$77.55 million
Price / Sales
2.59
Cash Flow
$3.90 per share
Price / Cash Flow
16.09
Book Value
$14.92 per share
Price / Book
4.21

Miscellaneous

Outstanding Shares
3,200,000
Free Float
1,733,000
Market Cap
$200.99 million
Optionable
Not Optionable
Beta
0.06

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:PDEX) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners